Compare RCI & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCI | ZBH |
|---|---|---|
| Founded | 1960 | 1927 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Industrial Specialties |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 18.6B |
| IPO Year | 2002 | 2001 |
| Metric | RCI | ZBH |
|---|---|---|
| Price | $33.22 | $103.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 27 |
| Target Price | $37.54 | ★ $116.24 |
| AVG Volume (30 Days) | 1.2M | ★ 2.2M |
| Earning Date | 10-23-2026 | 11-04-2026 |
| Dividend Yield | ★ 4.38% | 0.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.25 |
| Revenue | N/A | ★ $8,231,500,000.00 |
| Revenue This Year | $4.17 | $4.65 |
| Revenue Next Year | $1.01 | $3.30 |
| P/E Ratio | ★ $4.12 | $32.14 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $29.26 | $79.12 |
| 52 Week High | $41.14 | $112.55 |
| Indicator | RCI | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 55.99 |
| Support Level | $31.64 | $93.37 |
| Resistance Level | $35.21 | $112.55 |
| Average True Range (ATR) | 0.88 | 3.42 |
| MACD | 0.07 | 0.35 |
| Stochastic Oscillator | 58.19 | 48.94 |
Rogers Communications is one of Canada's "Big 3" telecom service providers, offering wireless and broadband services nationally, but with strongholds in Ontario, British Columbia, and Alberta. The firm serves 11 million postpaid and 1 million prepaid wireless customers and 5 million broadband customers with nearly 11 million homes passed. Rogers also operates a media segment, primarily known for ownership of three major Toronto sports teams: baseball's Blue Jays, hockey's Maple Leafs, and basketball's Raptors. Additionally, the firm operates multiple broadcast networks, radio stations, and public venues in the Rogers Centre.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.